The impact of irregularly rising prostate-specific antigen and “impending failure” on the apparent outcome of localized prostate cancer following radiotherapy
- 1 March 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (4) , 957-963
- https://doi.org/10.1016/s0360-3016(00)01431-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustnessInternational Journal of Radiation Oncology*Biology*Physics, 2000
- 4 Preliminary results of a randomized dose-escalation study comparing 70 GY to 78 GY for the treatment of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- The Correlation Between the Astro Consensus Panel Definition of Biochemical Failure and Clinical Outcome for Patients with Prostate Cancer Treated with External Beam IrradiationInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical controlInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostateRadiotherapy and Oncology, 1996
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcomeInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994